Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Papillomavirus Infections × adacel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Specimen Handling 4 Human Papillomavirus Recombinant Vaccine nonavalent 4 Papillomavirus Vaccines 3 Human Papillomavirus DNA Tests 3 Colposcopy 3 Radiotherapy, Intensity-Modulated 2 Methods 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Early Intervention, Educational 2 Cisplatin 2 human papillomavirus vaccine, L1 type 16, 18 1 artesunic acid 1 artenimol 1 artemisinin 1 adacel 1 Vaccines 1 Tetanus Toxoid 1 Sodium Chloride 1 Platinum 1 Patient Navigation 1 Nimorazole 1 Mass Screening 1 Interviews as Topic 1 Injections 1 High-Energy Shock Waves 1 Educational Status 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 Diphtheria Toxoid 1 Clinical Protocols 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡